Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5-a]pyrimidine-Based Inhibitors Targeting the DCN1–UBC12 Protein–Protein Interaction
Shuai Wang, Lijie Zhao, Xiaojing Shi, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 5, pp. 2772-2797
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment
Wen Li, Feifei Li, Xia Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 124
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application
Shuai Wang, Xiaohan Yuan, Saiqi Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113218-113218
Closed Access | Times Cited: 108
Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy
Liang Shen, Bo Wang, ShaoPeng Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 922-951
Closed Access | Times Cited: 17
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
Shuai Wang, Fen‐Er Chen
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114334-114334
Closed Access | Times Cited: 64
Triazole-fused pyrimidines in target-based anticancer drug discovery
Xing‐Jie Dai, Lei-Peng Xue, Shi‐Kun Ji, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115101-115101
Closed Access | Times Cited: 33
Anticancer drug discovery by targeting cullin neddylation
Qing Yu, Yihan Jiang, Yi Sun
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 5, pp. 746-765
Open Access | Times Cited: 59
Targeting neddylation E2s: a novel therapeutic strategy in cancer
Yi‐Chao Zheng, Yan-Jia Guo, Bo Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 42
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy
Lisha Zhou, Xiongzhi Lin, Jin Zhu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Targeting NEDD8 suppresses surgical stress-facilitated metastasis of colon cancer via restraining regulatory T cells
Yi Jiang, Shenjia Gao, Hao Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Targeting Protein Neddylation for Cancer Therapy
Lisha Zhou, Lijun Jia
Advances in experimental medicine and biology (2020), pp. 297-315
Closed Access | Times Cited: 43
Advances in Cancer Treatment by Targeting the Neddylation Pathway
Wenbin Gai, Zhiqiang Peng, Cui Hua Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 35
Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity
Haibin Zhou, Jianfeng Lü, Krishnapriya Chinnaswamy, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Targeting cullin neddylation for cancer and fibrotic diseases
Zhangxu He, Wei-guang Yang, Dan Zengyangzong, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 5017-5056
Open Access | Times Cited: 13
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators
Shuai Wang, Saiqi Wang, Qiu‐Xu Teng, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15979-15996
Closed Access | Times Cited: 37
E2 conjugating enzymes: A silent but crucial player in Ubiquitin Biology
Somya Parashar, Aastha Kaushik, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2025), pp. 102740-102740
Closed Access
Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation
Ho Shin Kim, Jared T. Hammill, Daniel C. Scott, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 18, pp. 8429-8442
Open Access | Times Cited: 33
An exhaustive compilation on chemistry of triazolopyrimidine: A journey through decades
Pankaj Kumar Singh, Shalki Choudhary, Aanchal Kashyap, et al.
Bioorganic Chemistry (2019) Vol. 88, pp. 102919-102919
Closed Access | Times Cited: 30
Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance
Shuai Wang, Saiqi Wang, Qiu‐Xu Teng, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 16187-16204
Closed Access | Times Cited: 25
Discovery of the 2,4-disubstituted quinazoline derivative as a novel neddylation inhibitor for tumor therapy
Jingtian Su, Mengyu Li, Yuanyuan Chang, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107237-107237
Closed Access | Times Cited: 3
Brønsted acid-promoted ‘on–water’ C(sp3)-H functionalization for the synthesis of isoindolinone/[1,2,4]triazolo[1,5-a]pyrimidine derivatives targeting the SKP2-CKS1 interaction
Shuo Yuan, Sixi Wang, Min Zhao, et al.
Chinese Chemical Letters (2019) Vol. 31, Iss. 2, pp. 349-352
Closed Access | Times Cited: 28
Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes
Qing Yu, Zhiguo Hu, Yanwen Shen, et al.
Neoplasia (2020) Vol. 22, Iss. 4, pp. 179-191
Open Access | Times Cited: 26
Discovery of [1,2,4]triazolo[1,5-a]pyrimidines derivatives as potential anticancer agents
Jin-Ling Huo, Shuai Wang, Xiaohan Yuan, et al.
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113108-113108
Closed Access | Times Cited: 25
Discovery of novel indole derivatives that inhibit NEDDylation and MAPK pathways against gastric cancer MGC803 cells
Dong‐Jun Fu, Xinxin Cui, Ting Zhu, et al.
Bioorganic Chemistry (2021) Vol. 107, pp. 104634-104634
Closed Access | Times Cited: 23
Cu(OTf)2-Catalyzed Intramolecular Radical Cascade Reactions for the Diversity-Oriented Synthesis of Quinoline-Annulated Polyheterocyclic Frameworks
Shuo Yuan, Jingya Zhang, Danqing Zhang, et al.
Organic Letters (2021) Vol. 23, Iss. 4, pp. 1445-1450
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top